<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="Iminosugar treatment of Vero or CHME3 cells prior to ZIKV" exact="infection" post="resulted in significant inhibition of ZIKV replication over 48"/>
 <result pre="change in the expression levels of key antiviral genes. Following" exact="infection" post="with three different strains of ZIKV, iminosugar-treated Vero or"/>
 <result pre="public health emergency due to the increased association of ZIKV" exact="infections" post="with fetal abnormalities, autoimmune disease, and neurological disorders. ZIKV"/>
 <result pre="to the increased association of ZIKV infections with fetal abnormalities," exact="autoimmune" post="disease, and neurological disorders. ZIKV has been relatively uninvestigated"/>
 <result pre="Oehler et al., 2014). Until this point, symptoms of ZIKV" exact="infection" post="were mild, including fever, rash, and malaise. Since its"/>
 <result pre="islands and the Americas, ZIKV has been associated with increased" exact="infection" post="rates, neurological pathologies such as Guillain-Barré syndrome, meningoencephalitis, and"/>
 <result pre="been associated with increased infection rates, neurological pathologies such as" exact="Guillain-Barré syndrome," post="meningoencephalitis, and myelitis in adults, and microcephaly in infants"/>
 <result pre="infection rates, neurological pathologies such as Guillain-Barré syndrome, meningoencephalitis, and" exact="myelitis" post="in adults, and microcephaly in infants (Musso and Gubler,"/>
 <result pre="such as Guillain-Barré syndrome, meningoencephalitis, and myelitis in adults, and" exact="microcephaly" post="in infants (Musso and Gubler, 2016). By phylogenetic analysis,"/>
 <result pre="By phylogenetic analysis, ZIKV isolates cluster into two lineages, namely" exact="African" post="and Asian (Haddow et al., 2012). Epidemic ZIKV strains"/>
 <result pre="two lineages, namely African and Asian (Haddow et al., 2012)." exact="Epidemic" post="ZIKV strains from French Polynesia and the Americas cluster"/>
 <result pre="in the Asian lineage of ZIKV (Lanciotti et al., 2016)." exact="African" post="strains have been shown to induce a more cytopathic"/>
 <result pre="and maintain cell viability to allow a longer period of" exact="viral" post="persistence and replication (Sheridan et al., 2018). One of"/>
 <result pre="2018). One of the most alarming outcomes associated with ZIKV" exact="infection" post="during pregnancy is microcephaly (Petersen et al., 2016). While"/>
 <result pre="most alarming outcomes associated with ZIKV infection during pregnancy is" exact="microcephaly" post="(Petersen et al., 2016). While research is still ongoing"/>
 <result pre="the relationship, Asian lineage ZIKVs have been most associated with" exact="microcephaly" post="(Anfasa et al., 2017; Bhatnagar et al., 2017; Yuan"/>
 <result pre="al., 2018; Jaeger et al., 2019; Udenze et al., 2019)." exact="Microcephaly" post="is a condition in which fetuses are born with"/>
 <result pre="as well as the brain of fetuses and infants with" exact="microcephaly" post="(Oliveira Melo et al., 2016; Mlakar et al., 2016)."/>
 <result pre="macrophages and trophoblasts, fetal brain cells are targets of ZIKV" exact="infection" post="(Kendra et al., 2016). In vitro studies have shown"/>
 <result pre="astrocytes, microglia, and oligodendrocyte precursor cells are vulnerable to ZIKV" exact="infection" post="(Tang et al., 2016; Retallack et al., 2016). An"/>
 <result pre="ability to limit ZIKV replication in mothers and/or reduce ZIKV" exact="infection" post="of fetal brain cells may prevent microcephaly. Current strategies"/>
 <result pre="the prevention and control of ZIKV involves vector control and" exact="symptomatic" post="therapy. Despite the considerable need for novel antiviral therapies,"/>
 <result pre="no FDA-approved drugs to prevent and treat ZIKV infection. A" exact="primary" post="focus of current ZIKV antiviral research is directed at"/>
 <result pre="and DNA viruses in vitro by interrupting proper folding of" exact="viral" post="proteins (Mehta et al., 1998; Chang et al., 2013a,"/>
 <result pre="in α-glucosidases I or II showed no clinical evidence of" exact="recurrent" post="viral infections, and cells derived from these patients were"/>
 <result pre="α-glucosidases I or II showed no clinical evidence of recurrent" exact="viral" post="infections, and cells derived from these patients were unable"/>
 <result pre="and cells derived from these patients were unable to support" exact="infection" post="by multiple viruses such as HIV, influenza A virus,"/>
 <result pre="viruses such as HIV, influenza A virus, adenovirus, poliovirus and" exact="vaccinia" post="virus (Sadat et al., 2014; Alonzi et al., 2017)."/>
 <result pre="during ZIKV replication (Wu et al., 2002). ZIKV replication and" exact="viral" post="RNA synthesis occurs on an extended network of modified"/>
 <result pre="endoplasmic reticulum (ER) membranes. The ZIKV capsid protein binds to" exact="viral" post="RNA during the process of nucleocapsid assembly, forming the"/>
 <result pre="report has examined the role of these compounds in ZIKV" exact="infection" post="(Ma et al., 2018). In these studies, hepatocellular carcinoma"/>
 <result pre="in ZIKV infection (Ma et al., 2018). In these studies," exact="hepatocellular carcinoma" post="cells with the knockout of α-glucosidases I or II"/>
 <result pre="ZIKV infection (Ma et al., 2018). In these studies, hepatocellular" exact="carcinoma" post="cells with the knockout of α-glucosidases I or II"/>
 <result pre="α-glucosidases I or II supported a reduced level of ZIKV" exact="viral" post="replication compared with wild-type cells (Ma et al., 2018)."/>
 <result pre="comparison to ER α-glucosidase II (Ma et al., 2018). ZIKV" exact="viral" post="replication was reduced in embryonic kidney cells when cells"/>
 <result pre="is no information about potential differential sensitivity to iminosugars between" exact="African" post="or Asian lineage ZIKVs. Here, we report the ability"/>
 <result pre="the method of Reed and Muench (Reed and Muench, 1938)." exact="African" post="green monkey kidney Vero (CCL-81) cells were purchased from"/>
 <result pre="was established through SV40-dependent immortalization of a human fetal brain-derived" exact="primary" post="microglia culture. Human microglial cell line CHME3 was cultured"/>
 <result pre="strain PRVABC59, IBH30656 or MEX 2-81 at a multiplicity of" exact="infection" post="(MOI) of 1 in infection medium consisting of DMEM"/>
 <result pre="2-81 at a multiplicity of infection (MOI) of 1 in" exact="infection" post="medium consisting of DMEM supplemented with 5% FBS and"/>
 <result pre="supplemented with 5% FBS and 1% antibiotic/antimycotic solution. The CHME3" exact="infection" post="medium was additionally supplemented with 0.1% non-essential amino acids"/>
 <result pre="shown that ER α-glucosidase inhibitor, Celgosivir prevents DENV secretion in" exact="primary" post="human macrophages with an EC50 of 5 μM and"/>
 <result pre="a previously described quantitative reverse transcription-polymerase chain reaction (qRT-PCR) and" exact="infectious" post="virus titration in Vero cells (Reed and Muench, 1938;"/>
 <result pre="infected with PRVABC59 either at MOI 0.5 or 5 in" exact="infection" post="medium. After 2 h of incubation with the virus,"/>
 <result pre="removed, cells were washed with phosphate buffered saline, and fresh" exact="infection" post="medium containing 1 μM of castanospermine, celgosivir or DNJ"/>
 <result pre="supernatants were harvested and stored at −80°C until use for" exact="viral" post="RNA extraction. Viral RNA was extracted from 50 μl"/>
 <result pre="and stored at −80°C until use for viral RNA extraction." exact="Viral" post="RNA was extracted from 50 μl of sample using"/>
 <result pre="was extracted from 50 μl of sample using the MagMAX-96" exact="Viral" post="RNA Isolation Kit (Applied Biosystems, Foster City, CA, United"/>
 <result pre="known TCID50 value. Cell culture supernatants were titrated for the" exact="infectious" post="virus in Vero cells, and titer was expressed as"/>
 <result pre="Assay (Promega) following the manufacturer’s instructions. LDH is a soluble" exact="stable" post="cytosolic enzyme present in many cell types which is"/>
 <result pre="(Promega) following the manufacturer’s instructions. LDH is a soluble stable" exact="cytosolic" post="enzyme present in many cell types which is rapidly"/>
 <result pre="cells was removed, cells were washed with PBS, and fresh" exact="infection" post="medium containing 1 μM celgosivir was added. Negative control"/>
 <result pre="μM celgosivir was added. Negative control wells were added with" exact="infection" post="medium without celgosivir. Three wells were used for each"/>
 <result pre="used for each treatment. At 24, 48, and 72 h," exact="total" post="RNA was extracted from cells using the RNeasy Plus"/>
 <result pre="manufacturer’s protocol. Complementary DNA was synthesized from 1 μg of" exact="total" post="RNA using 4 μl of qScript cDNA SuperMix (5x)"/>
 <result pre="the manufacturer’s instructions. Expression of retinoic acid-inducible gene 1 (RIGI)," exact="melanoma" post="differentiation-associated protein 5 (MDA5), interferon regulatory factor 7 (IRF7),"/>
 <result pre="With Iminosugars Up to a Concentration of 100 μM A" exact="total" post="of three iminosugars, namely castanospermine, celgosivir, andDNJ, were tested"/>
 <result pre="hpi. ZIKV RNA levels were determined by qRT-PCR assay (C,D)." exact="Infectious" post="ZIKV titration was determined by TCID50 assay (E,F). Data"/>
 <result pre="assay (C,D). Data represent mean values of four biological replicates." exact="Infectious" post="ZIKV titration was determined by TCID50 assay (E,F). Error"/>
 <result pre="hpi. ZIKV RNA levels were determined by qRT-PCR assay (C,D)." exact="Infectious" post="ZIKV titration was determined by TCID50 assay (E,F). Data"/>
 <result pre="assay (E,F). Data represent mean values of four biological replicates." exact="Infectious" post="ZIKV titration was determined by TCID50 assay (E,F). Error"/>
 <result pre="the ability of iminosugars to inhibit ZIKV replication, we compared" exact="viral" post="RNA and infectious virus in culture supernatants of ZIKV-infected"/>
 <result pre="iminosugars to inhibit ZIKV replication, we compared viral RNA and" exact="infectious" post="virus in culture supernatants of ZIKV-infected Vero and CHME3"/>
 <result pre="the Americas with increased morbidity compared with ZIKV of the" exact="African" post="lineage, we first investigated infection with the Asian-lineage strain"/>
 <result pre="compared with ZIKV of the African lineage, we first investigated" exact="infection" post="with the Asian-lineage strain PRVABC59, isolated in 2015 from"/>
 <result pre="celgosivir (Figure 2C) or DNJ (Figure 3C). Similar reductions in" exact="viral" post="RNA were seen between Vero cells infected at both"/>
 <result pre="5. While a similar significant reduction (p ≤ 0.0253) of" exact="viral" post="RNA was also observed in iminosugar-treated CHME3 cells infected"/>
 <result pre="at MOI 0.5 (Figures 1D, 2D, 3D), the reduction in" exact="viral" post="RNA was not significant between castanospermine-treated and control cells"/>
 <result pre="1D). Similarly, a statistically significant reduction (p ≤ 0.0433) in" exact="infectious" post="PRVABC59 ZIKV titers as measured by TCID50 quantification was"/>
 <result pre="at MOI 0.5 which was not statistically significant. ZIKV PRVABC59" exact="Infection" post="Increases Antiviral Gene Expression in CHME3 Cells The antiviral"/>
 <result pre="antiviral genes MDA5, RIG-I, MX1, IRF7, IFNβ, and ISG15 following" exact="infection" post="with PRVABC59 ZIKV (Figure 4). All genes were slightly"/>
 <result pre="Cells Iminosugars are known to reduce virus replication by inhibiting" exact="viral" post="glycoprotein maturation and not by altering the cellular antiviral"/>
 <result pre="5 Iminosugar endoplasmic-reticulum α-glucosidase inhibitor treatment restores cell viability following" exact="infection" post="with Zika virus (ZIKV) in Vero and CHME3 cells."/>
 <result pre="Vero and CHME3 cells. Cell viability at 72 h post" exact="infection" post="as measured by MTS assay of castanospermine- (A,B), celgosivir-"/>
 <result pre="such as fetal neural progenitor cells, cranial neural crest cells," exact="peripheral" post="neurons, dendritic cells and microglia (Manangeeswaran et al., 2016;"/>
 <result pre="could affect the apoptosis response in PRVABC59 ZIKV-infected cells. CHME3" exact="infection" post="with ZIKV strain PRVABC59 at MOI 1 substantially increased"/>
 <result pre="from CHME3 cells 48 (A) and 72 (B) hours following" exact="infection" post="with ZIKV PRVABC59 with and without celgosivir. Data points"/>
 <result pre="Celgosivir Treatment Is Associated With Lower Cell Necrosis After ZIKV" exact="Infection" post="Zika virus has been shown to cause necrosis in"/>
 <result pre="to determine if iminosugar use could reduce ZIKV-induced necrosis. CHME3" exact="infection" post="with PRVABC59 ZIKV alone substantially increased LDH levels at"/>
 <result pre="7B). FIGURE 7 Celgosivir rescues CHME3 cells from necrosis following" exact="infection" post="with Zika virus (ZIKV). Absorbance measurements of LDH levels"/>
 <result pre="from CHME3 cells 48 (A) and 72 (B) hours following" exact="infection" post="with ZIKV PRVABC59 at MOI of 1 with and"/>
 <result pre="**p &amp;lt; 0.01, ***p &amp;lt; 0.001. Iminosugars Inhibit Replication of" exact="Multiple" post="ZIKV Strains Iminosugars were further evaluated for antiviral activity"/>
 <result pre="reduction of cytopathic effect (cell death) after ZIKV infection. An" exact="African" post="lineage strain isolated from a human patient in Nigeria"/>
 <result pre="8 Iminosugar endoplasmic-reticulum α-glucosidase inhibitor treatment restores cell viability following" exact="infection" post="Zika virus (ZIKV) strains IBH30656 or MEX 2-81 in"/>
 <result pre="2-81 in Vero cells. Cell viability at 72 h post" exact="infection" post="as measured by MTS assay of castanospermine- (A,B), celgosivir-"/>
 <result pre="vaccines or antivirals to prevent damaging neurological syndromes such as" exact="Guillain-Barré syndrome" post="and microcephaly, which are multifactorial diseases that still need"/>
 <result pre="or antivirals to prevent damaging neurological syndromes such as Guillain-Barré" exact="syndrome" post="and microcephaly, which are multifactorial diseases that still need"/>
 <result pre="while maintaining cellular antiviral response. We found that following ZIKV" exact="infection" post="in both Vero and CHME3 cells infected at MOI"/>
 <result pre="al., 2011), and castanospermine has previously been shown to inhibit" exact="viral" post="spread and virion secretion of all four serotypes of"/>
 <result pre="to the developing brain. Iminosugars are known to interfere with" exact="viral" post="protein synthesis as well as the maturation of viral"/>
 <result pre="with viral protein synthesis as well as the maturation of" exact="viral" post="particles (Chang et al., 2013a). The results of the"/>
 <result pre="2017). We found that iminosugar treatment resulted both in reduced" exact="viral" post="RNA and lower infectious virus in cell culture supernatant"/>
 <result pre="that iminosugar treatment resulted both in reduced viral RNA and" exact="lower" post="infectious virus in cell culture supernatant compared with vehicle-treated"/>
 <result pre="iminosugar treatment resulted both in reduced viral RNA and lower" exact="infectious" post="virus in cell culture supernatant compared with vehicle-treated cells,"/>
 <result pre="to production of fewer virus particles. Notably, the reduction in" exact="infectious" post="virus titer was much higher than the reduction in"/>
 <result pre="infectious virus titer was much higher than the reduction in" exact="viral" post="RNA. This observation suggests that there are also defective"/>
 <result pre="also defective particles suggesting inefficient virus maturation in iminosugar-treated cells." exact="Viral" post="RNA measured by qRT-PCR that is not accounted for"/>
 <result pre="RNA measured by qRT-PCR that is not accounted for by" exact="infectious" post="virus particles likely represents viral RNA encapsulated in non-infectious"/>
 <result pre="is not accounted for by infectious virus particles likely represents" exact="viral" post="RNA encapsulated in non-infectious virions (Sayce et al., 2016)."/>
 <result pre="cell death by iminosugars occurs through reducing the secretion of" exact="infectious" post="virus particles or by secreting particles that are less"/>
 <result pre="particles that are less infectious. It is well-known that the" exact="infection" post="of cells with ZIKV induces the upregulation of antiviral"/>
 <result pre="2018). Our study also found that in CHME3 cells ZIKV" exact="infection" post="resulted in upregulation of type I interferon (IFNβ), interferon-stimulated"/>
 <result pre="that in CHME3 cells ZIKV infection resulted in upregulation of" exact="type I" post="interferon (IFNβ), interferon-stimulated genes (MX-1 and ISG15), pattern recognition"/>
 <result pre="reducing magnitude of ZIKV infection. Since the results of misfolded" exact="viral" post="proteins includes not only reduced successful virus assembly and"/>
 <result pre="innate immune response pathways as well as apoptosis to limit" exact="viral infection" post="(Smith, 2014). We found a significant increase in activated"/>
 <result pre="immune response pathways as well as apoptosis to limit viral" exact="infection" post="(Smith, 2014). We found a significant increase in activated"/>
 <result pre="of caspases in neural progenitor cells at 24 h after" exact="infection" post="with ZIKV (Souza et al., 2016). Notably, there was"/>
 <result pre="apoptosis of microglia is unclear, particularly in the developing brain." exact="Primary" post="astrocytes, the cell type that is most abundant in"/>
 <result pre="developing brain (Reemst et al., 2016), that supported persistent ZIKV" exact="infection" post="of both African and Asian lineage ZIKV were relatively"/>
 <result pre="et al., 2016), that supported persistent ZIKV infection of both" exact="African" post="and Asian lineage ZIKV were relatively resistant to virus-induced"/>
 <result pre="that lack of apoptosis could lead to persistence of ZIKV" exact="infection" post="in developing brain cells and lead to ZIKV-induced damage"/>
 <result pre="developing brain cells and lead to ZIKV-induced damage such as" exact="microcephaly" post="(Limonta et al., 2018). A key pathogenicity factor in"/>
 <result pre="microcephaly (Limonta et al., 2018). A key pathogenicity factor in" exact="viral infection" post="is necrosis of virus-infected cells, which leads to pro-inflammatory"/>
 <result pre="(Limonta et al., 2018). A key pathogenicity factor in viral" exact="infection" post="is necrosis of virus-infected cells, which leads to pro-inflammatory"/>
 <result pre="(Gomez Perdiguero et al., 2015). Our data showed that ZIKV" exact="infection" post="of CHME3 microglial cells results in substantial necrosis as"/>
 <result pre="limit inflammatory responses in vivo and help limit the clinical" exact="disease" post="associated with ZIKV infection. That treatment of ZIKV-infected CHME3"/>
 <result pre="the most promising as evidenced by its ability to reduce" exact="viral" post="RNA and infectious virus titers in both Vero and"/>
 <result pre="as evidenced by its ability to reduce viral RNA and" exact="infectious" post="virus titers in both Vero and CHME3 cells with"/>
 <result pre="2016). Celgosivir has been considered in human clinical trials against" exact="hepatitis" post="C virus, HIV and dengue virus (Durantel, 2009; Sung"/>
 <result pre="ability against dengue virus in very vulnerable mice with disrupted" exact="type I" post="and type II interferon response is reason to believe"/>
 <result pre="virus in very vulnerable mice with disrupted type I and" exact="type II" post="interferon response is reason to believe that an optimized"/>
 <result pre="The authors declare that the research was conducted in the" exact="absence of" post="any commercial or financial relationships that could be construed"/>
 <result pre="R.DoriaJ. G.OlmoI. G.et al. (2017). N-Methyl-d-Aspartate (n.d.) receptor blockade prevents" exact="neuronal" post="death induced by Zika Virus infection.mBio8;e350-17. 10.1128/mBio.00350-1728442607 DatemaR.OlofssonS.RomeroP. A."/>
 <result pre="A. (1987). Inhibitors of protein glycosylation and glycoprotein processing in" exact="viral" post="systems.Pharmacol. Ther.33221–286. 10.1016/0163-7258(87)90066-03310033 DickG. W.KitchenS. F.HaddowA. J. (1952). Zika"/>
 <result pre="of combination N-butyl-deoxynojirimycin (SC-48334) and zidovudine in patients with HIV-1" exact="infection" post="and 200–500 CD4 Cells/mm.JAIDS7139–147. 7905523 FletcherT.IIIPtakR.BartramS.HallidayS.BuckheitR.Jr.MoravecR.et al. (2000). for"/>
 <result pre="al. (2007). Antiviral profiles of novel iminocyclitol compounds against bovine" exact="viral" post="diarrhea virus, west nile virus, dengue virus and hepatitis"/>
 <result pre="(2007). Antiviral profiles of novel iminocyclitol compounds against bovine viral" exact="diarrhea" post="virus, west nile virus, dengue virus and hepatitis B"/>
 <result pre="bovine viral diarrhea virus, west nile virus, dengue virus and" exact="hepatitis" post="B Virus.Antivir. Chem. Chemother.1849–59. 10.1177/09563202070180010517354651 HaddowA. D.SchuhA. J.YasudaC. Y.KasperM."/>
 <result pre="A.GorenL. R.CrooksC. M.MoriartyR. V.WeilerA. M.et al. (2019). Zika viruses of" exact="African" post="and Asian lineages cause fetal harm in a mouse"/>
 <result pre="genes for the normalization of RT-qpcr expression studies in human" exact="breast cancer" post="cell lines treated with and without transient transfection.PLoS One10:e0117058."/>
 <result pre="for the normalization of RT-qpcr expression studies in human breast" exact="cancer" post="cell lines treated with and without transient transfection.PLoS One10:e0117058."/>
 <result pre="in human breast cancer cell lines treated with and without" exact="transient" post="transfection.PLoS One10:e0117058. 10.1371/journal.pone.011705825617865 LivingstoneM.SikströmK.RobertP. A.UzéG.LarssonO.PellegriniS. (2015). Assessment of mTOR-dependent"/>
 <result pre="S.HessR.RossR.PiontkivskaH. (2018). Seasonality of birth defects in West Africa: could" exact="congenital" post="Zika syndrome be to blame?F1000Res.7:159. 10.12688/f1000research.13858.230079237 ManangeeswaranM.IrelandD. D.VerthelyiD. (2016)."/>
 <result pre="Seasonality of birth defects in West Africa: could congenital Zika" exact="syndrome" post="be to blame?F1000Res.7:159. 10.12688/f1000research.13858.230079237 ManangeeswaranM.IrelandD. D.VerthelyiD. (2016). Zika (PRVABC59)"/>
 <result pre="syndrome be to blame?F1000Res.7:159. 10.12688/f1000research.13858.230079237 ManangeeswaranM.IrelandD. D.VerthelyiD. (2016). Zika (PRVABC59)" exact="infection" post="is associated with T cell Infiltration and neurodegeneration in"/>
 <result pre="with T cell Infiltration and neurodegeneration in CNS of immunocompetent" exact="neonatal" post="C57Bl/6 Mice.PLoS Pathog.12:e1006004. 10.1371/journal.ppat.100600427855206 MeertensL.LabeauA.DejarnacO.CiprianiS.SinigagliaL.Bonnet-MadinL.et al. (2017). Axl mediates"/>
 <result pre="and TLR3 Synergistically Play an Important Role in Restriction of" exact="Dengue" post="Virus Infection.PLoS Negl. Trop. Dis.5:e926. 10.1371/journal.pntd.000092621245912 OehlerE.WatrinL.LarreP.ILeparc-GoffartS. L.ValourF.BaudouinL.et al."/>
 <result pre="Infection.PLoS Negl. Trop. Dis.5:e926. 10.1371/journal.pntd.000092621245912 OehlerE.WatrinL.LarreP.ILeparc-GoffartS. L.ValourF.BaudouinL.et al. (2014). Zika" exact="virus infection" post="complicated by Guillain-Barre syndrome–case report, French Polynesia.Euro Surveill19:20720. 24626205"/>
 <result pre="Negl. Trop. Dis.5:e926. 10.1371/journal.pntd.000092621245912 OehlerE.WatrinL.LarreP.ILeparc-GoffartS. L.ValourF.BaudouinL.et al. (2014). Zika virus" exact="infection" post="complicated by Guillain-Barre syndrome–case report, French Polynesia.Euro Surveill19:20720. 24626205"/>
 <result pre="S.MalingerG.XimenesR.SzejnfeldP. O.Alves SampaioS.Bispo de FilippisA. M. (2016). Zika virus intrauterine" exact="infection" post="causes fetal brain abnormality and microcephaly: tip of the"/>
 <result pre="G.CarvalhoT. G.CostaV. V.Alves-SilvaJ.FerrariC. Z.Izidoro-ToledoT. C.et al. (2017). Zika virus promotes" exact="neuronal" post="cell death in a non-cell autonomous manner by triggering"/>
 <result pre="J.et al. (2013). An iminosugar with potent inhibition of dengue" exact="virus infection" post="in vivo.Antivir. Res.9835–43. 10.1016/j.antiviral.2013.01.00423376501 PetersenL. R.JamiesonD. J.PowersA. M.HoneinM. A."/>
 <result pre="al. (2013). An iminosugar with potent inhibition of dengue virus" exact="infection" post="in vivo.Antivir. Res.9835–43. 10.1016/j.antiviral.2013.01.00423376501 PetersenL. R.JamiesonD. J.PowersA. M.HoneinM. A."/>
 <result pre="QuX.PanX.WeidnerJ.YuW.AlonziD.XuX.et al. (2011). Inhibitors of endoplasmic reticulum α-Glucosidases potently suppress" exact="hepatitis" post="C Virus virion assembly and release.Antimicrob. Agents Chemotherapy551036–1044. 10.1128/AAC.01319-1021173177"/>
 <result pre="azithromycin.Proc. Natl. Acad. Sci. U.S.A.11314408–14413. 10.1073/pnas.161802911327911847 RichardA. S.ShimB.-S.KwonY.-C.ZhangR.OtsukaY.SchmittK.et al. (2017)." exact="infection" post="of human fetal endothelial cells distinguishes Zika virus from"/>
 <result pre="KeatingM.Silva-FlanneryL.MuehlenbachsA.GaryJ. (2016). Notes from the field: evidence of Zika Virus" exact="infection" post="in brain and placental tissues from two congenitally infected"/>
 <result pre="Commun.492603–607.28108286 SadatM. A.MoirS.ChunT.-W.LussoP.KaplanG.WolfeL.et al. (2014). Glycosylation, hypogammaglobulinemia, and resistance to" exact="viral" post="infections.N. Engl. J. Med.3701615–1625. 10.1056/NEJMoa130284624716661 SayceA. C.AlonziD. S.KillingbeckS. S.TyrrellB."/>
 <result pre="(2014). High basal expression of interferon-stimulated genes in human bronchial" exact="epithelial" post="(BEAS-2B) cells contributes to influenza A virus resistance.PLoS One9:e109023."/>
 <result pre="resistance.PLoS One9:e109023. 10.1371/journal.pone.010902325313647 SheridanM. A.BalaramanV.SchustD. J.EzashiT.RobertsR. M.FranzA. W. E. (2018)." exact="African" post="and Asian strains of Zika virus differ in their"/>
 <result pre="S. (2006). α-Glucosidase Inhibitors have a prolonged antiviral effect against" exact="hepatitis" post="B Virus through the sustained inhibition of the large"/>
 <result pre="L. A.PereiraC. S.CamposG. S.SardiS. I.FreitasL. A. R.et al. (2016). Zika" exact="virus infection" post="induces mitosis abnormalities and apoptotic cell death of human"/>
 <result pre="A.PereiraC. S.CamposG. S.SardiS. I.FreitasL. A. R.et al. (2016). Zika virus" exact="infection" post="induces mitosis abnormalities and apoptotic cell death of human"/>
 <result pre="endpoints of CELADEN: A randomized, placebo-controlled trial of celgosivir in" exact="dengue fever" post="patients.PLoS Negl. Trop. Dis.10:e0004851. 10.1371/journal.pntd.000485127509020 SwartwoutB.ZlotnickM.SaverA.McKennaC.BertkeA. (2017). Zika Virus"/>
 <result pre="Dis.10:e0004851. 10.1371/journal.pntd.000485127509020 SwartwoutB.ZlotnickM.SaverA.McKennaC.BertkeA. (2017). Zika Virus persistently and productively infects" exact="primary" post="adult sensory neurons in vitro.Pathogens6:49. 10.3390/pathogens604004929027940 TangH.HammackC.OgdenS. C.WenZ.QianX.LiY.et al."/>
 <result pre="10.1371/journal.pntd.000485127509020 SwartwoutB.ZlotnickM.SaverA.McKennaC.BertkeA. (2017). Zika Virus persistently and productively infects primary" exact="adult" post="sensory neurons in vitro.Pathogens6:49. 10.3390/pathogens604004929027940 TangH.HammackC.OgdenS. C.WenZ.QianX.LiY.et al. (2016)."/>
 <result pre="vitro.Pathogens6:49. 10.3390/pathogens604004929027940 TangH.HammackC.OgdenS. C.WenZ.QianX.LiY.et al. (2016). Zika Virus Infects Human" exact="Cortical" post="Neural Progenitors and Attenuates Their Growth.Cell Stem Cell18587–590. 10.1016/j.stem.2016.02.01626952870"/>
 <result pre="aberrant glycoprotein synthesis.Antivir. Res.1011–26. 10.1016/0166-3542(88)90011-32852915 TiwariS. K.DangJ.QinY.LichinchiG.BansalV.RanaT. M. (2017). Zika" exact="virus infection" post="reprograms global transcription of host cells to allow sustained"/>
 <result pre="glycoprotein synthesis.Antivir. Res.1011–26. 10.1016/0166-3542(88)90011-32852915 TiwariS. K.DangJ.QinY.LichinchiG.BansalV.RanaT. M. (2017). Zika virus" exact="infection" post="reprograms global transcription of host cells to allow sustained"/>
 <result pre="allow sustained infection.Emerg. Microbes Infect.6e24. 10.1038/emi.2017.928442752 UdenzeD.ITrusN. B.GerdtsV.KarniychukU. (2019). The" exact="African" post="strain of Zika virus causes more severe in utero"/>
 <result pre="African strain of Zika virus causes more severe in utero" exact="infection" post="than Asian strain in a porcine fetal transmission model.Emerg."/>
 <result pre="G. (2016). Optimizing celgosivir therapy in mouse models of dengue" exact="virus infection" post="of serotypes 1 and 2: The search for a"/>
 <result pre="(2016). Optimizing celgosivir therapy in mouse models of dengue virus" exact="infection" post="of serotypes 1 and 2: The search for a"/>
 <result pre="efficacy of celgosivir in a lethal mouse model for dengue" exact="virus infection" post="informs dosing regimen for a proof of concept clinical"/>
 <result pre="of celgosivir in a lethal mouse model for dengue virus" exact="infection" post="informs dosing regimen for a proof of concept clinical"/>
 <result pre="WhitbyK.PiersonT. C.GeissB.LaneK.EngleM.ZhouY.et al. (2005). Castanospermine, a potent inhibitor of dengue" exact="virus infection" post="in vitro and in vivo.J. Virol.798698–8706. 10.1128/jvi.79.14.8698-8706.200515994763 WhitbyK.TaylorD.PatelD.AhmedP.TymsA. S."/>
 <result pre="C.GeissB.LaneK.EngleM.ZhouY.et al. (2005). Castanospermine, a potent inhibitor of dengue virus" exact="infection" post="in vitro and in vivo.J. Virol.798698–8706. 10.1128/jvi.79.14.8698-8706.200515994763 WhitbyK.TaylorD.PatelD.AhmedP.TymsA. S."/>
 <result pre="castanospermine) against the pestivirus BVDV: implications for the treatment of" exact="hepatitis" post="C.Antivir. Chem. Chemother.15141–151. 10.1177/09563202040150030415266896 collab: WHO, (2016). Zika Virus,"/>
 <result pre="hepatitis C.Antivir. Chem. Chemother.15141–151. 10.1177/09563202040150030415266896 collab: WHO, (2016). Zika Virus," exact="Microcephaly" post="and Guillain-Barré syndrome.Geneva: WHO. WuS.-F.LeeC.-J.LiaoC.-L.DwekR. A.ZitzmannN.LinY.-L. (2002). Antiviral effects"/>
 <result pre="Chem. Chemother.15141–151. 10.1177/09563202040150030415266896 collab: WHO, (2016). Zika Virus, Microcephaly and" exact="Guillain-Barré" post="syndrome.Geneva: WHO. WuS.-F.LeeC.-J.LiaoC.-L.DwekR. A.ZitzmannN.LinY.-L. (2002). Antiviral effects of an"/>
</results>
